Series D funding round for NGM Biopharmaceuticals raising $58M in March 2015
Series D funding round for NGM Biopharmaceuticals raising $58M in March 2015
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$260M
Top Valuation
-
NGM Biopharmaceuticals raised $58M in a Series D round.
The round was announced on 03/01/15.